Horizon Investments LLC raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 76.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,671 shares of the semiconductor company's stock after purchasing an additional 2,886 shares during the quarter. Horizon Investments LLC's holdings in Synopsys were worth $3,238,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also made changes to their positions in the company. Kieckhefer Group LLC bought a new position in shares of Synopsys during the 4th quarter valued at approximately $27,000. Whipplewood Advisors LLC bought a new position in Synopsys during the fourth quarter valued at $33,000. Sierra Ocean LLC purchased a new stake in shares of Synopsys in the fourth quarter valued at $39,000. Newbridge Financial Services Group Inc. bought a new stake in shares of Synopsys in the 4th quarter worth about $51,000. Finally, Versant Capital Management Inc boosted its stake in shares of Synopsys by 109.3% during the 4th quarter. Versant Capital Management Inc now owns 113 shares of the semiconductor company's stock worth $55,000 after purchasing an additional 59 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Stock Down 0.3 %
NASDAQ:SNPS traded down $1.39 during mid-day trading on Friday, reaching $448.60. The company's stock had a trading volume of 3,362,089 shares, compared to its average volume of 1,020,823. Synopsys, Inc. has a 1 year low of $425.73 and a 1 year high of $624.80. The stock has a fifty day moving average of $491.19 and a 200-day moving average of $506.23. The firm has a market capitalization of $69.36 billion, a PE ratio of 30.90, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16.
Insider Activity
In other news, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the transaction, the chief executive officer now directly owns 70,922 shares in the company, valued at approximately $32,890,077.50. This trade represents a 13.81 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CRO Richard S. Mahoney sold 20,838 shares of the company's stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now owns 1,460 shares of the company's stock, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 47,909 shares of company stock worth $22,794,835. 0.62% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of analysts recently weighed in on the stock. Morgan Stanley reduced their price objective on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a research report on Monday, February 24th. Robert W. Baird reduced their price target on Synopsys from $644.00 to $630.00 and set an "outperform" rating on the stock in a report on Thursday, December 5th. Needham & Company LLC restated a "buy" rating and set a $650.00 price objective on shares of Synopsys in a report on Thursday, February 27th. Rosenblatt Securities reaffirmed a "buy" rating and issued a $660.00 price objective on shares of Synopsys in a research report on Tuesday, February 25th. Finally, Piper Sandler decreased their target price on Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $638.58.
Read Our Latest Stock Analysis on Synopsys
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.